A Study to Evaluate YF087 in Subjects With MSI-H or dMMR Advanced Solid Tumors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is an open-label, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of YF087 in subjects with Microsatellite Instability-High (MSI-H) or Mismatch Repair-Deficient (dMMR) advanced solid tumors.
Epistemonikos ID: 790b074c62a210d6837b2d587400ef63e7dd1823
First added on: Sep 10, 2026